{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:01:07Z","timestamp":1790143267173,"version":"4.0.1"},"reference-count":57,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["febs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Molecular Oncology"],"abstract":"<jats:p>Although microwave ablation (MWA) constitutes an effective targeted treatment for liver cancer, the mechanisms driving high recurrence rates remain poorly understood. To elucidate these processes, we established an incomplete MWA (iMWA) model in rabbit VX2 tumors and conducted proteomic profiling of residual tumors at Days 3 (D3) and 14 (D14) postablation. By integrating genomic profiles from mouse radiofrequency ablation (RFA) models, we identified 81 and 92 upregulated proteins at D3 and D14, respectively. Functional enrichment analysis (STRING and Enrichr) revealed acute injury response and extracellular matrix (ECM) remodeling predominating at D3, then markedly declining by D14. Conversely, pathways associated with signal transduction, tumorigenesis, and immune pathways were substantially upregulated at D14. Specifically, protein\u2013protein interaction (PPI) analysis revealed that macrophage remodeling and immune checkpoint networks are functionally coupled at D14 to orchestrate an immunosuppressive microenvironment. Stouffer analysis confirmed the shift from matrix remodeling at an early stage to late\u2010stage oncogenic signal transduction and immune suppression at progression. Overall, these findings characterize the dynamic mechanisms of postablation residual tumor growth and highlight potential therapeutic targets to inhibit protumorigenic pathways while enhancing antitumor immunity.<\/jats:p>","DOI":"10.1002\/1878-0261.70337","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:08:48Z","timestamp":1790140128000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2581-1819","authenticated-orcid":false,"given":"Yu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Radiology Campus Virchow\u2010Klinikum, Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"},{"name":"Experimental Clinical Research Center (ECRC) at Charit\u00e9 \u2013 University Medical Center Berlin and Max\u2010Delbr\u00fcck\u2010Centrum f\u00fcr Molekulare Medizin (MDC)  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6224-2441","authenticated-orcid":false,"given":"Yubei","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiology Campus Virchow\u2010Klinikum, Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"},{"name":"Experimental Clinical Research Center (ECRC) at Charit\u00e9 \u2013 University Medical Center Berlin and Max\u2010Delbr\u00fcck\u2010Centrum f\u00fcr Molekulare Medizin (MDC)  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-9940","authenticated-orcid":false,"given":"Nikolaus","family":"Berndt","sequence":"additional","affiliation":[{"name":"Department of Molecular Toxicology German Institute of Human Nutrition Potsdam\u2010Rehbruecke (DIfE)  Nuthetal Germany"},{"name":"Department of Radiology Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9792-3861","authenticated-orcid":false,"given":"Michael","family":"M\u00fclleder","sequence":"additional","affiliation":[{"name":"Core Facility High\u2010Throughput Mass Spectrometry, Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Textoris\u2010Taube","sequence":"additional","affiliation":[{"name":"Core Facility High\u2010Throughput Mass Spectrometry, Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Radiology Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1810-3529","authenticated-orcid":false,"given":"Matthias","family":"Stechele","sequence":"additional","affiliation":[{"name":"Department of Radiology University Hospital, LMU Munich  Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Ramtke","sequence":"additional","affiliation":[{"name":"Department of Radiology Campus Virchow\u2010Klinikum, Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"},{"name":"Experimental Clinical Research Center (ECRC) at Charit\u00e9 \u2013 University Medical Center Berlin and Max\u2010Delbr\u00fcck\u2010Centrum f\u00fcr Molekulare Medizin (MDC)  Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraga Nahum","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Department of Radiology University Hospital, LMU Munich  Munich Germany"},{"name":"Goldyne Savad Institute of Gene Therapy and Division of Image\u2010Guided Therapy and Interventional Oncology, Department of Radiology Hadassah Hebrew University Medical Center  Jerusalem Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2115-6728","authenticated-orcid":false,"given":"Lynn Jeanette","family":"Savic","sequence":"additional","affiliation":[{"name":"Department of Radiology Campus Virchow\u2010Klinikum, Charit\u00e9 \u2013 University Medical Center Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt\u2010Universit\u00e4t zu Berlin  Berlin Germany"},{"name":"Experimental Clinical Research Center (ECRC) at Charit\u00e9 \u2013 University Medical Center Berlin and Max\u2010Delbr\u00fcck\u2010Centrum f\u00fcr Molekulare Medizin (MDC)  Berlin Germany"},{"name":"Berlin Institute of Health at Charit\u00e9 \u2013 University Medical Center Berlin  Berlin Germany"},{"name":"Department of Radiology and Nuclear Medicine Otto\u2010von\u2010Guericke University Magdeburg  Magdeburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"e_1_2_11_2_1","article-title":"The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the global burden of disease study 2023","volume":"25","author":"GBD 2023 Cancer Collaborators","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"issue":"3","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update","volume":"84","author":"Reig M","year":"2026","journal-title":"J Hepatol"},{"key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","article-title":"Thermal ablation versus surgical resection of small\u2010size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non\u2010inferiority trial","volume":"26","author":"Lei S","year":"2025","journal-title":"Lancet Oncol"},{"key":"e_1_2_11_6_1","first-page":"871","article-title":"Ablation treatment for peripheral lung cancers","volume":"78","author":"Yamauchi Y","year":"2025","journal-title":"Kyobu Geka"},{"issue":"7","key":"e_1_2_11_7_1","article-title":"Microwave ablation vs. single\u2010needle radiofrequency ablation for the treatment of HCC up to 4\u2009cm: a randomized\u2010controlled trial","volume":"13","author":"Sugimoto K","year":"2024","journal-title":"JHEP Rep"},{"issue":"28","key":"e_1_2_11_8_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112175","article-title":"Advancements in microwave ablation for tumor treatment and future directions","volume":"7","author":"Dong F","year":"2025","journal-title":"iScience"},{"issue":"9","key":"e_1_2_11_9_1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000580","article-title":"Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using an ex vivo calf liver model","volume":"94","author":"Pillai K","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41598-021-03802-x","article-title":"Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial","volume":"12","author":"Radosevic A","year":"2022","journal-title":"Sci Rep"},{"key":"e_1_2_11_11_1","first-page":"249","article-title":"Clinical efficacy of high\u2010power microwave ablation in the treatment of hepatocellular carcinoma and analysis of risk factors for recurrence","volume":"18","author":"Zhang NN","year":"2015","journal-title":"J Pract Hepatol"},{"key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1478-3231.2005.01051.x","article-title":"A multi\u2010step, incremental expansion method for radio frequency ablation: optimization of the procedure to prevent increases in intra\u2010tumor pressure and to reduce the ablation time","volume":"25","author":"Kotoh K","year":"2005","journal-title":"Liver Int"},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1148\/radiol.2015150080","article-title":"Hepatic radiofrequency ablation\u2010induced stimulation of distant tumor growth is suppressed by c\u2010met inhibition","volume":"279","author":"Ahmed M","year":"2016","journal-title":"Radiology"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner A","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13046-023-02716-y","article-title":"Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation","volume":"42","author":"Shi ZR","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_2_11_16_1","article-title":"Molecular MRI of tumor\u2010associated macrophages to monitor immunosuppression after incomplete ablation in liver cancer","author":"He Y","year":"2026","journal-title":"Adv Sci"},{"issue":"1","key":"e_1_2_11_17_1","doi-asserted-by":"crossref","DOI":"10.1186\/s41747-026-00687-1","article-title":"Hepatic radiofrequency ablation induces global cellular activation throughout the liver","volume":"10","author":"Stechele M","year":"2026","journal-title":"Eur Radiol Exp"},{"key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/s41467-025-60456-3","article-title":"CD200R1\u2010CD200 checkpoint inhibits phagocytosis differently from SIRP\u03b1\u2010CD47 to suppress tumor growth","volume":"16","author":"Li J","year":"2025","journal-title":"Nat Commun"},{"key":"e_1_2_11_19_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.gore.2026.102121","article-title":"Local immunosuppressive microenvironment underlies reduced responsiveness to imiquimod treatment in recurrent or residual cervical HSIL","volume":"65","author":"Muntinga CLP","year":"2026","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-017-1447-1","article-title":"TLR2 stimulation impairs anti\u2010inflammatory activity of M2\u2010like macrophages, generating a chimeric M1\/M2 phenotype","volume":"19","author":"Quero L","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"e_1_2_11_21_1","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-026-04392-2","article-title":"Macrophage\u2010derived CTSZ promotes prostate cancer progression via \u03b1V\u03b23 integrin\u2010mediated activation of the AKT\/FOXO1\/JUNB signaling axis","author":"Liu Y","year":"2026","journal-title":"Cancer Cell Int"},{"issue":"1","key":"e_1_2_11_22_1","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2026.2670152","article-title":"Thyroid cancer\u2010derived exosomal SPP1 promotes tumor progression by driving macrophage M2 polarization through the CD44\/JAK2\/STAT3 signaling pathway","volume":"22","author":"Yang J","year":"2026","journal-title":"Organogenesis"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.reth.2025.07.004","article-title":"Inhibition of the TLR4\/RAGE pathway by clearance of extracellular HMGB1 is a potential therapeutic target for radiation\u2010damaged salivary glands","volume":"30","author":"Takashi I","year":"2025","journal-title":"Regen Ther"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","DOI":"10.2147\/IJGM.S610534","article-title":"Innovative insights into interleukin\u2010mediated macrophage polarization: metabolic reprogramming and inflammatory pathway crosstalk in chronic kidney disease and therapeutic implications\u2010a narrative review","volume":"19","author":"Jiang Z","year":"2026","journal-title":"Int J Gen Med"},{"issue":"1","key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12943-025-02471-y","article-title":"Integrated multi\u2010omics identifies a CD54+ iCAF\u2010ITGAL+ macrophage niche driving immunosuppression via CXCL8\u2010PDL1 axis in cervical cancer","volume":"24","author":"Chen F","year":"2025","journal-title":"Mol Cancer"},{"key":"e_1_2_11_26_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110972","article-title":"Lactic acid\u2010induced M2\u2010like macrophages facilitate tumor cell migration and invasion via the GPNMB\/CD44 axis in oral squamous cell carcinoma","volume":"124","author":"Lin Y","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"e_1_2_11_27_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2023.104731","article-title":"CD300f signalling induces inhibitory human monocytes\/macrophages","volume":"390","author":"Sutherland SIM","year":"2023","journal-title":"Cell Immunol"},{"issue":"1","key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12935-024-03309-1","article-title":"High LGALS3 expression induced by HCP5\/hsa\u2010miR\u201027b\u20103p correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma","volume":"24","author":"Ren Y","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"1","key":"e_1_2_11_29_1","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70536","article-title":"Prognostic significance of LGALS3BP in triple\u2010negative breast cancer: implications for immune infiltration and therapeutic response","volume":"40","author":"Wang C","year":"2026","journal-title":"J Biochem Mol Toxicol"},{"issue":"19","key":"e_1_2_11_30_1","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70802","article-title":"TGFBI inhibits the Pyroptosis of macrophages to ameliorate septic shock","volume":"29","author":"Zou S","year":"2025","journal-title":"J Cell Mol Med"},{"issue":"7","key":"e_1_2_11_31_1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165544","article-title":"TGF\u2010\u03b21 induces PD\u20101 expression in macrophages through SMAD3\/STAT3 cooperative signaling in chronic inflammation","volume":"9","author":"Lei Z","year":"2024","journal-title":"JCI Insight"},{"issue":"9","key":"e_1_2_11_32_1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1158\/2159-8290.CD-17-1033","article-title":"CD38\u2010mediated immunosuppression as a mechanism of tumor cell escape from PD\u20101\/PD\u2010L1 blockade","volume":"8","author":"Chen L","year":"2018","journal-title":"Cancer Discov"},{"issue":"7980","key":"e_1_2_11_33_1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-023-06511-9","article-title":"CD300ld on neutrophils is required for tumour\u2010driven immune suppression","volume":"621","author":"Wang C","year":"2023","journal-title":"Nature"},{"issue":"20","key":"e_1_2_11_34_1","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.3390\/ijms242015072","article-title":"Emerging immune checkpoint molecules on cancer cells: CD24 and CD200","volume":"24","author":"Moon SY","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"e_1_2_11_35_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s43856-025-00786-x","article-title":"Acquired resistance to immune checkpoint therapy is caused by glycoprotein non\u2010metastatic melanoma protein B signal cascade","volume":"5","author":"Chung JS","year":"2025","journal-title":"Commun Med"},{"issue":"12","key":"e_1_2_11_36_1","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304114","article-title":"Extracellular matrix\u2010bioinspired anisotropic topographical cues of electrospun nanofibers: a strategy of wound healing through macrophage polarization","volume":"13","author":"Park H","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"e_1_2_11_37_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20210679","article-title":"Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression","volume":"136","author":"Kolesnikoff N","year":"2022","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"e_1_2_11_38_1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6602384","article-title":"PI3K\/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2\u2010induced cell death","volume":"92","author":"Hotfilder M","year":"2005","journal-title":"Br J Cancer"},{"issue":"1","key":"e_1_2_11_39_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/CS20201236","article-title":"Therapeutic targeting of TGF\u2010\u03b2 in cancer: hacking a master switch of immune suppression","volume":"135","author":"Bulk J","year":"2021","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"e_1_2_11_40_1","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1172\/JCI123360","article-title":"An osteopontin\/CD44 immune checkpoint controls CD8+ T\u00a0cell activation and tumor immune evasion","volume":"128","author":"Klement JD","year":"2018","journal-title":"J Clin Invest"},{"key":"e_1_2_11_41_1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T\u00a0cells into the stroma of human lung tumors","volume":"122","author":"Salmon H","year":"2012","journal-title":"J Clin Invest"},{"key":"e_1_2_11_42_1","article-title":"Tumor microenvironment\u2010responsive nanomedicine: monitoring and modulating the tumor microenvironment for precision cancer therapy","volume":"21","author":"He J","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"e_1_2_11_43_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","article-title":"Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy","volume":"18","author":"Hu Q","year":"2025","journal-title":"J Hematol Oncol"},{"issue":"1","key":"e_1_2_11_44_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13244-026-02246-z","article-title":"Development and evaluation of a predictive model based on multi\u2010frequency magnetic resonance elastography for high\u2010risk esophagogastric varices in patients with cirrhotic portal hypertension","volume":"17","author":"Lv W","year":"2026","journal-title":"Insights Imaging"},{"issue":"17","key":"e_1_2_11_45_1","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.7150\/thno.114459","article-title":"Molecular and functional MRI enables detection of cardiac fibrosis and evaluation of treatment response after chordin\u2010like 1 gene therapy in myocardial infarction","volume":"15","author":"Amoiradaki K","year":"2025","journal-title":"Theranostics"},{"issue":"14","key":"e_1_2_11_46_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1402578","article-title":"In vivo characterization of brain tumor biomechanics: magnetic resonance elastography in intracranial B16 melanoma and GL261 glioma mouse models","volume":"11","author":"Janas A","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"e_1_2_11_47_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71716-5","article-title":"Elastin\u2010specific MR probe for visualization and evaluation of an interleukin\u20101\u03b2 targeted therapy for atherosclerosis","volume":"14","author":"Mangarova DB","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"e_1_2_11_48_1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S2468-1253(24)00247-4","article-title":"Combination locoregional and systemic therapies in hepatocellular carcinoma","volume":"10","author":"Zhong BY","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"e_1_2_11_49_1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/hepr.13353","article-title":"Role of cyclin\u2010dependent kinases (CDKs) in hepatocellular carcinoma: therapeutic potential of targeting the CDK signaling pathway","volume":"49","author":"Shen S","year":"2019","journal-title":"Hepatol Res"},{"key":"e_1_2_11_50_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.942341","article-title":"CDK4\/6 inhibitors improve the anti\u2010tumor efficacy of lenvatinib in hepatocarcinoma cells","volume":"12","author":"Digiacomo G","year":"2022","journal-title":"Front Oncol"},{"key":"e_1_2_11_51_1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2018.07.010","article-title":"Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia\u2013mutated kinase\u2013mediated DNA damage response","volume":"102","author":"Huang CY","year":"2018","journal-title":"Eur J Cancer"},{"issue":"1","key":"e_1_2_11_52_1","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-026-04382-6","article-title":"An all\u2010in\u2010one theranostic platform for enhanced TACE: self\u2010developing embolization with dual\u2010targeted arsenic trioxide delivery","volume":"24","author":"Yuan T","year":"2026","journal-title":"J Nanobiotechnol"},{"key":"e_1_2_11_53_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-065X.2008.00659.x","article-title":"Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins","volume":"224","author":"Dimitriou ID","year":"2008","journal-title":"Immunol Rev"},{"key":"e_1_2_11_54_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.580241","article-title":"Ablation reboots the response in advanced hepatocellular carcinoma with stable or atypical response during PD\u20101 therapy: a proof\u2010of\u2010concept study","volume":"10","author":"Lyu N","year":"2020","journal-title":"Front Oncol"},{"issue":"10415","key":"e_1_2_11_55_1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(23)01796-8","article-title":"Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high\u2010risk hepatocellular carcinoma (IMbrave050): a randomised, open\u2010label, multicenter, phase 3 trial","volume":"402","author":"Qin S","year":"2023","journal-title":"Lancet"},{"issue":"16","key":"e_1_2_11_56_1","doi-asserted-by":"crossref","first-page":"e14513","DOI":"10.1200\/JCO.2024.42.16_suppl.e14513","article-title":"A first\u2010in\u2010human study to evaluate a personalized neoantigen\u2010based mRNA\u2010loaded dendritic cell vaccine, in combination with ablation, in patients with hepatocellular carcinoma","volume":"42","author":"Liang P","year":"2024","journal-title":"J Clin Oncol"},{"key":"e_1_2_11_57_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871829","article-title":"Rabbit VX2 liver tumor model: a review of clinical, biology, histology, and tumor microenvironment characteristics","volume":"12","author":"Pascale F","year":"2022","journal-title":"Front Oncol"},{"issue":"12","key":"e_1_2_11_58_1","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1111\/mec.12309","article-title":"Annotated genes and nonannotated genomes: cross\u2010species use of gene ontology in ecology and evolution research","volume":"22","author":"Primmer CR","year":"2013","journal-title":"Mol Ecol"}],"container-title":["Molecular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1878-0261.70337","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1878-0261.70337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:08:55Z","timestamp":1790140135000},"score":1,"resource":{"primary":{"URL":"https:\/\/febs.onlinelibrary.wiley.com\/doi\/10.1002\/1878-0261.70337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":57,"alternative-id":["10.1002\/1878-0261.70337"],"URL":"https:\/\/doi.org\/10.1002\/1878-0261.70337","archive":["Portico"],"relation":{},"ISSN":["1574-7891","1878-0261"],"issn-type":[{"value":"1574-7891","type":"print"},{"value":"1878-0261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"2026-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1878-0261.70337"}}